β-Myrcene Mitigates Colon Inflammation by Inhibiting MAP Kinase and NF-κB Signaling Pathways - Almarzooqi, Saeeda; Venkataraman, Balaji; Raj, Vishnu; Alkuwaiti, Sultan Ali Abdulla; Das, Karuna M.; Collin, Peter D.; Adrian, Thomas E.; Subramanya, Sandeep B. (Molecules (Basel, Switzerland), 2022)
Keywords: Animals; Colitis - chemically induced; Colitis - drug therapy; Colitis - metabolism; Colitis, Ulcerative - chemically induced; Colitis, Ulcerative - drug therapy; Colitis, Ulcerative - metabolism; Colon; Colon - metabolism; Crohn's disease; Cytokines; Development and progression; Dextran; Dextran Sulfate - adverse effects; Disease Models, Animal; Drug dosages; DSS colitis; Edema; Enzymes; Histology; Inflammation; Inflammation - metabolism; Inflammatory bowel disease; inflammatory bowel diseases; Inflammatory Bowel Diseases - pathology; Kinases; MAPKs; Medical colleges; Mice; Mitogen-Activated Protein Kinases - metabolism; Mitogens; NF-kappa B - metabolism; NF-κB signaling; Phosphorylation; Protein expression; Protein kinases; Proteins; RNA; Signal Transduction; Sulfates; Tofacitinib; Tumor Necrosis Factor-alpha - metabolism; Ulcerative colitis; β-myrcene; United States; Massachusetts; Illinois; NF-κB signaling; β-myrcene; DSS colitis; inflammatory bowel diseases; MAPKs